Adamis Pharmaceuticals Corp·4

Jan 27, 4:19 PM ET

Adamis Pharmaceuticals Corp 4

4 · Adamis Pharmaceuticals Corp · Filed Jan 27, 2016

Insider Transaction Report

Form 4
Period: 2016-01-25
Moll Thomas
Vice President of Research
Transactions
  • Award

    Employee Stock Option (right to buy)

    2016-01-25+67,18367,183 total
    Exercise: $4.10Exp: 2026-01-25Common Stock (67,183 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the grant date.

Documents

1 file
  • 4
    moll-form4_012516.xmlPrimary

    OWNERSHIP DOCUMENT